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Iranian Naja oxiana (the Elapidae family) known as cobra snake inhabits in the northwestern part of Iran. This 
study aimed to evaluate the edematogenic potency of the crude venom with intraplantar injection into mice. 
Additionally, the inhibitory effects of three different drugs (i.e., promethazine, dexamethasone, and piroxicam) 
on paw edema were examined. Moreover, the gelatinase activity of this venom was assessed using the 
zymography method. Paw edema was induced by the intraplantar injection of different concentrations of the 
venom (0.5-5 μg dissolved in 50 μl of normal saline) into the mice (six in each group). It was estimated through 
the measurement of the increase in the paw thickness (%) with a digital caliper. The paws were pretreated and 
the rate of changes was measured after the venom injection. Pathological findings in the treated paws were 
evaluated with hematoxylin and eosin staining. Paw thickness reached its maximum amount within 5 min and 
resolved after 1 h. This venom had no gelatinase activity using the zymography method ruling out its role in 
edema. It caused non-hemorrhagic diffuse edema with the infiltration of inflammatory cells (i.e., leukocytes and 
lymphocytes) in the dermis. Intraperitoneal pretreatment with drugs significantly inhibited the venom-induced 
(1 μg/paw) edema; however, all the mice died unexpectedly a day after piroxicam injection. This in vitro and in 
vivo preliminary study demonstrated for the first time that N. oxiana venom-induced non-hemorrhagic edema in 
a short time. Dexamethasone (phospholipase A2 inhibitor; 1 mg/kg) and promethazine (H1 inhibitor; 5 mg/kg) 
decreased the venom-induced edema (P<0.001). It is suggested to carry out further studies to identify different 
mediators in venom-induced edema formation.  
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Évaluation Expérimentale de L'œdème de la Patte Postérieure de Souris Induit par le Venin Iranien de 
Naja oxiana  
Résumé: Le Naja oxiana iranien (la famille des Elapidae) connu sous le nom de serpent cobra habite dans la 
partie nord-ouest de l'Iran. Cette étude visait à évaluer le pouvoir œdématogène du venin brut par injection 
intraplantaire chez les souris. De plus, les effets inhibiteurs de trois médicaments différents (c.-à-d., 












Several studies suggest that snake envenomation is a 
major threat to humans in the tropical and subtropical 
areas of the world. It is estimated that more than 5 
million individuals are annually bitten by this animal; 
nevertheless, the number of mortalities is within the 
range of 20,000-125,000 due to a lack of accurate 
information in some countries (Warrell, 2010; 
Longbottom et al., 2018). Iranian N. oxiana (Caspian 
cobra) belongs to the Elapidae family and usually 
inhabits the Transcaspian region in the northwestern 
parts of Iran.  
The results of a 10-year survey revealed that the 
number of mortalities due to snake envenomation was 
67 in Iran (Dehghani et al., 2014). However, such 
approaches have failed to address the definite number 
of individuals envenomed with the N. oxiana in which 
the venom yield is more than other snakes living in Iran 
(Latifi, 1984). Furthermore, the lowest level of lethal 
dose 50% makes this venomous animal more deadly 
than other cobras (Akbari et al., 2010). The evidence 
suggests that snakebites cause many regional (i.e., 
edema, erythema, and ecchymosis) and general 
complications, such as cardiac arrest, respiratory 
paralysis, neurotoxicity, coagulopathies, and shock 
(Monzavi et al., 2014). Envenomation usually causes 
severe pain and edema accompanied by neurological 
complications, including weakness, ataxia, and 
peripheral nerve palsy (Kularatne et al., 2009).  
Numerous studies have been carried out on the 
toxicological profiles of different snakes, including the 
Elapidae family; nonetheless, there has been no 
experimental study conducted on biochemical events 
contributing to edema formation in N. oxiana. The 
primary purpose of the present study was to identify the 
dose-dependent and time-course elements in 
inflammation in mice paw edema as a model. In 
addition, the protective effects of dexamethasone, 
promethazine, and piroxicam on paw edema were 
evaluated. For the first time, the present study aimed to 
determine the biochemical and pathological events 
responsible for N. oxiana envenomation.  
Material and Methods 
Animals and Chemicals. The crude venom was 
obtained from adult specimens in Razi Vaccine and 
Serum Research Institute, Karaj, Iran. The latex coating 
method was used to milk the venom since the fangs of 
this snake do not move and are fixed in the upper jaw. 
It was lyophilized and stored at a temperature of -20°C. 
The venom solutions were prepared with physiological 
saline at the moment of use, and the protein content 
was measured according to the method of Bradford 
 
gélatinase de ce venin a été évaluée à l'aide de la méthode de zymographie. L'œdème de la patte a été induit par 
l'injection intraplantaire de différentes concentrations de venin (0.5-5 μg dissous dans 50 μl de solution saline 
normale) chez les souris (six dans chaque groupe). Il a été estimé par la mesure de l'augmentation de l'épaisseur de 
la patte (%) avec un pied à coulisse numérique. Les pattes ont été prétraitées et le taux de changement a été mesuré 
après l'injection de venin. Les résultats pathologiques dans les pattes traitées ont été évalués par coloration à 
l'hématoxyline et à l'éosine. L'épaisseur de la patte a atteint sa quantité maximale en 5 min et s'est résolue après 1 h. 
Ce venin n'avait aucune activité gélatinase en utilisant la méthode de zymographie excluant son rôle dans l'œdème. 
Il a provoqué un œdème diffus non hémorragique avec infiltration de cellules inflammatoires (c'est-à-dire, 
leucocytes et lymphocytes) dans le derme. Le prétraitement intrapéritonéal avec des médicaments a inhibé de 
manière significative l'œdème induit par le venin (1 μg/patte); cependant, toutes les souris sont mortes de manière 
inattendue un jour après l'injection de piroxicam. Cette étude préliminaire in vitro et in vivo a démontré pour la 
première fois que le venin de N. oxiana induisait un œdème non hémorragique en peu de temps. La dexaméthasone 
(inhibiteur de la phospholipase A2; 1 mg/kg) et la prométhazine (inhibiteur de H1; 5 mg/kg) ont diminué l'œdème 
provoqué par le venin (P<0,001). Il est suggéré de mener des études supplémentaires pour identifier différents 
médiateurs dans la formation d'œdème induit par le venin. 
Mots-clés: Naja oxiana iranien, Gélatinase, œdème de la patte, venin, phospholipase A2 




(Bradford, 1976). Dexamethasone, promethazine, and 
piroxicam were purchased from Santa Cruz 
Biotechnology Incorporation (Shanghai, China). Other 
reagents were analytical grades from commercial 
sources.                                                                                                              
SDS-PAGE and Proteolytic Activities. A sample 
of N. oxiana venom was heated at a temperature of 
95°C for 5 min and cooled on ice. Electrophoresis was 
performed using sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) with 
12.5% acrylamide by the method of Laemmli (1970). 
The gels were stained for 1 h by Coomassie Blue R-
250 (C.I. 42660, Sigma-Aldrich, USA) and silver 
nitrate for the detection of protein bands. Protein 
quantitation was performed using a prestained protein 
ladder (CSL-BBL; Cleaver Co., UK) within the range 
of 11-245 kDa. In order to evaluate the gelatinolytic 
properties of the venom, SDS-PAGE was 
copolymerized with 0.1% gelatin as a substrate in the 
12.5% gel. Different concentrations of the venom 
were prepared using Tris-Glycine sample buffer (2X, 
Catalog number LC2673, USA) and remained at room 
temperature for 5 min. Electrophoresis was performed 
at cold temperature, and the gels were washed in the 
incubation buffer containing Triton X-100 for 1 h in 
order to remove SDS. They were incubated at reaction 
buffer (Triton X-100 1%, Tris HCl 50 mM, pH 7.5, 
and 5 mM CaCl2 dissolved in 250 ml of distilled 
water) at a temperature of 37°C for 16 h. They were 
stained with 0.125% Coomassie Blue G-250 for 1 h 
and destained in methanol (400 ml) and acetic acid 
(100 ml) dissolved in 1 L. The clear zone of the gel 
showed the gelatinolytic capacities of N. oxiana 
venom.                                                                                             
Experimental Protocol. Venom in different doses 
(range: 0.5-5 μg) dissolved in normal saline (50 μl) 
was subcutaneously injected into the subplantar region 
in the right hind paw among different groups of mice 
(six in each group). The contralateral paws received  
the same amount of normal saline as a negative 
control. Paw thickness was measured at different 
times (i.e., 5, 10, 15, 30, and 60 min) after venom 
injection with the aid of a digital caliper (Guanglu 
Co., China). The edema was measured as the 
percentage of the difference in paw thickness between 
the right hind paw and contralateral paws. More than 
1 μg/paw of venom was not used in further 
experiments since it was lethal. 
Effects of Drugs on Edema. This study was 
performed according to previous articles with minor 
modifications (de Faria et al., 2001; Lopes et al., 2017). 
Groups of mice were intraperitoneally (IP) pretreated 
with dexamethasone (phospholipase A2 inhibitor; 
Santa Cruz Biotechnology Incorporation; 1 mg/kg) and 
piroxicam (cyclooxygenase inhibitor; Santa Cruz 
Biotechnology Incorporation; 1 mg/kg) 30 min before 
venom injection (1 μg/paw). In the case of the 
promethazine (H1 inhibitor; Santa Cruz Biotechnology 
Incorporation; 5 mg/kg), it was IP injected 15 min 
before venom instillation. Paw thickness was measured 
and analyzed within 1 h after the venom injection in 
different time intervals.                                                                                                                  
Pathological Examination. The animals’ right paws 
were cut off at the tibiotarsal points in this experiment. 
They were immediately kept in 10% formaldehyde solution 
for hematoxylin and eosin staining in order to evaluate 
subplantar edema, leukocyte infiltration, and hemorrhagic 
areas with light microscopy (Olympus CX22, USA). The 
processed sections (with a thickness of 5 μm) were 
analyzed by a pathologist unaware of the experiment. Three 
specimens were examined from each mouse for the 
evaluation of the above-mentioned criteria. The 
physiological saline was injected with the same volume to 
the left paw and considered the control experiment.          
Statistical Analysis. The test results were expressed 
as mean±standard deviation. In addition, the data were 
analyzed using analysis of variance and SPSS software 
(version 16) followed by the Bonferroni test. The 
differences were considered statistically significant at 
P<0.01.  
Results 
Electrophoretic Analysis and Gelatinase Activities. 
The snake venom was analyzed using the SDS-PAGE 
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(12.5%) method with a constant voltage (100 Mv) and 
stained with Coomassie Blue and silver nitrate. In this 
case, seven different protein bands were revealed within 
the range of 11-120 kDa (Figure 1A). There were two 
major bands located below 17 kDa as well as four minor 
bands with approximate weights of 23, 56, 73, and 120 
kDa. The protein bands were revealed again after silver 
nitrate staining (Figure 1B). As shown in Figure 2, this 
venom had no gelatinolytic activities (20 μg); however, 
there was a clear band within the range of  40-60 kDa 
with increasing doses up to 200 μg.                                                                     
Increase in Paw Thickness (%). During the current 
experiment, there was non-hemorrhagic edema after 
venom injection into the mouse paw. Moreover, Figure 
3A illustrates the dose-response curve of the paw 
thickness with different amounts of N. oxiana venom. 
One μg/paw of the venom caused a significant increase 
(P<0.01) in paw edema, compared to the control. The 
injection of the escalating doses of the venom caused 
time- and dose-dependent increases in the paw 
sthickness without obvious signs of hemorrhage. There 




















24 h after the intraplantar injection. Paw thickness 
reached its maximum amount within 5 min, compared 
to that of the control (Figure 3B).                                        
Effects of Drugs on Venom-Induced Edema. 
According to Figure 4, promethazine (5 mg/kg, IP, 15 
min before venom injection), dexamethasone (1 mg/kg, 
IP, 30 min before venom injection), and piroxicam (1 
mg/kg, IP, 30 min before venom injection) had 
significant inhibitory effects on the paw thickness 
(P<0.01). Unexpectedly, all the animals expired 
following the piroxicam pretreatment after 1 day.                                          
Histopathological Analysis. The sections from mice 
treated with N. oxiana venom (1 μg/paw; 
intraplantarly) showed marked edema with moderate 
infiltration of the inflammatory cells, including 
neutrophils and lymphocytes. Furthermore, vascular 
congestion was observed in the dermal area. There was 
no evidence of hemorrhage and/or red blood cell 
extravasation (Figure 5A). In addition, there were no 
signs of pathological changes, such as edema, 
leukocyte infiltration, and vascular congestion, in the 












 Figure 1. Protein components of N. oxiana venom separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (12.5%) 
and stained with Coomassie Blue (lane 1:20, lane 2:10, and lane 3:5 µg) and silver nitrate (figures 1A and 1B); numbers indicating the 
molecular weight of size marker (CSL-BBL prestained protein ladder) 
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Figure 2. Gelatinase activities of N. oxiana venom using zymography method; N. oxiana venom (lane 1:20 μg and lane 2:200 μg) run 
on 12.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis containing substrates as previously mentioned; clear zone 
illustrating gelatinase activity; numbers on the right indicating molecular weight 
 
Figure 3A. Intensity of paw thickness in different doses of the venom (range: 0.5-5 μg) at 5 min; control group receiving saline with 
the same volume (50 μl); each point representing the mean±standard deviation of 6 mice; *P<0.01 and **P<0.001, compared to those 
reported for the control  

































































Figure 4. Inhibitory effects of piroxicam (1 mg/kg; intraperitoneally), promethazine (5 mg/kg; intraperitoneally), and dexamethasone 
(1 mg/kg; intraperitoneally) on venom-induced paw thickness determined 5 min after venom injection (1 μg/paw); each column 
representing the mean±standard deviation of 6 mice; *P<0.01 and **P<0.001, compared to those reported for the control 
 
Figure 5. Histopathological appearance of mouse food pad 5 min after intraplantar injection of physiological saline (7B; 50 μl) as a 
control and N. oxiana venom (7A; 1 μg/paw); in 7B, epidermis, dermis, and subdermis having a normal appearance; in 7A, extensive 
thickening of subdermis due to edema despite scattered infiltration of inflammatory cells (i.e., leukocytes and lymphocytes) in the 














Snake venoms are composed of different substances 
and enzymes, such as serine proteases, 
metalloproteinases (SVMP), phospholipases, and 
oxidases, which all together induce different kinds of 
clinical manifestations following envenomation (Burin 
et al., 2018). In reviewing the literature, several reports 
have shown that cobras (the Elapidae family) are 
distinguished by their neurotoxins causing different 
kinds of disorders, such as ptosis, respiratory paralysis, 
and drooling, in comparison to other snakes (Tan, 
1983). In addition, cutaneous necrosis, local 
inflammation, and edema are induced, especially in the 
lower extremities due to their cytotoxins (Feofanov et 
al., 2004).  
To date, no studies have been carried out on the role 
of N. oxiana venom in edema formation. The present 
study evaluated pathological malformations (i.e., 
edema, hemorrhage, and infiltration of inflammatory 
cells) in addition to the attenuated effects of the three 
different drugs (i.e., dexamethasone, promethazine, and 
piroxicam) on paw thickness. The electrophoretic 
profiles of the crude venom showed at least two major 
bands below 17 kDa, explaining its probable neurotoxic 
properties (Akbari et al., 2010). The presence of four 
minor bands (i.e., 23, 56, 73, and 120 kDa) in the 
present study (figures 1A and 1B) may stem from 
intraspecific variations (Abdel-Rahman et al., 2009).  
The gelatinase activity of this venom was assessed 
using the zymography method due to its possible 
involvement in edema. As depicted in Figure 2, this 
capacity was very low, compared to that of other 
snakes, ruling out its responsibilities in this process 
(Bee et al., 2001). The results of the current study 
revealed that the subplantar injection of the venom in 
mice caused paw edema which reduced after 1 h 
following envenomation (Figure 3). Furthermore, 
edema was accompanied by the abundant presence of 
the inflammatory cells, such as leukocytes and 
lymphocytes; nonetheless, there was no sign of 
hemorrhage (Figure 5). This pathological profile was 
similar to a previous experiment on Naja haje Arabica 
snake venom (Al-Asmari, 2005). In addition, the 
edematogenic potency of this venom in mice was more 
than that reported in a previous experiment carried out 
on Bothrops lanceolatus venom (1 μg/paw versus 12.5 
μg/paw) (de Faria et al., 2001).  
Previous studies have demonstrated the essential and 
integral role of the snake venom SVMP in hemorrhagic 
phenomenon after envenomation with viperid snake 
bites (Kularatne et al., 2009; Escalante et al., 2011). 
However, N. oxiana (Elapidae) had no gelatinase 
activity similar to another experiment performed on 
Naja haje Arabica (Al-Asmari and Abdo, 2006). 
Secretory phospholipase A2 is present in different 
snake venoms, including Vipera lebetina, Vipera berus, 
and Naja oxiana (Samel et al., 2013). The rapid onset 
of paw thickness (5 min) in this study and its decrease 
after 1 h showed the importance of the mediators, such 
as phospholipase A2, histamine, and serotonin, in this 
phenomenon (Cirino et al., 1989; de Faria et al., 2001).  
Additionally, the roles of the arachidonic acid 
metabolites and corticosteroids were considered in the 
present study. Piroxicam as a cyclooxygenase inhibitor 
significantly decreased the paw thickness (Figure 4), 
thereby implying that arachidonic acid metabolites via 
the cyclooxygenase pathway had a detrimental role in 
this process similar to previous experiments (Trebien 
and Calixto, 1989). Unexpectedly, in this experimental 
study, all the animals died 1 day after this intervention. 
It is required to carry out further experiments in order 
to determine the exact causes of mortality. Both 
promethazine as a histamine receptor antagonist and 
dexamethasone as a corticosteroid agent inhibited paw 
thickness more than piroxicam after the intraplantar 
venom injection (Figure 4). Therefore, it is evident that 
different kinds of receptors are involved in this process 
(Cirino et al., 1989; Trebien and Calixto, 1989; Al-
Asmari, 2003).  
Overall, the obtained findings of the present study 
indicated that N. oxiana venom-induced non-
hemorrhagic paw edema following intraplantar 
injection and reached its maximum amount 5 min 
following envenomation. This observational study 
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introduced promethazine and dexamethasone as 
effective drugs to counteract the edematogenic effect; 
however, there are still numerous unanswered 
questions about other responsible drugs and role of the 
polyvalent antivenom in this process.  
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